Apogee Therapeutics, Inc. (APGE)
80.76
+2.49
(+3.18%)
USD |
NASDAQ |
May 20, 14:23
Apogee Therapeutics EPS Diluted (Quarterly) : -1.064 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Rhythm Pharmaceuticals, Inc. | -0.8348 |
| Celcuity, Inc. | -0.9702 |
| Praxis Precision Medicines, Inc. | -3.205 |
| Disc Medicine, Inc. | -1.650 |
| Zura Bio Ltd. | -0.2159 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -74.11M |
| Total Expenses (Quarterly) | 74.11M |
| Enterprise Value | 4.849B |
| Earnings Yield | -5.36% |
| Normalized Earnings Yield | -5.359 |